06/19/2026
The Colton Consortium for Autoimmunity based at the University of Pennsylvania, last week announced a new $15 million, three-year investment from the Colton Foundation to strengthen scientific leadership, expand faculty expertise, and advance collaborative research to accelerate breakthroughs in autoimmune disease across its partner institutions at New York University, Tel Aviv University, and Yale University.
Autoimmune diseases affect millions worldwide and remain among the most complex conditions to diagnose, treat, and prevent. While advances in immunology have deepened our understanding of disease mechanisms, many conditions still lack effective therapies. At the same time, converging progress across academia, clinical research, and biopharma has created an ecosystem with transformative opportunities—one where coordinated investment and collaboration can translate discovery into meaningful advances for patients.
Read more: https://cftau.ca/the-colton-foundation-invests-15-million-to-advance-collaborative-autoimmune-disease-research/
University of Pennsylvania
New York University
Yale University
Tel Aviv University | אוניברסיטת תל-אביב